Molecular cytogenetics of lymphoma: where do we stand in 2010?

Kluin P & Schuuring E
(2011) Histopathology 58, 128–144
Molecular cytogenetics of lymphoma: where do we stand in 2010?

[1]  H. Höfler,et al.  Quantitative gene expression analysis in microdissected archival formalin-fixed and paraffin-embedded tumor tissue. , 2001, The American journal of pathology.

[2]  M. Neat,et al.  Detection of cryptic and variant IGH-MYC rearrangements in high-grade non-Hodgkin's lymphoma by fluorescence in situ hybridization: implications for cytogenetic testing. , 2010, Cancer genetics and cytogenetics.

[3]  Richard D. Kennedy,et al.  RNA expression analysis from formalin fixed paraffin embedded tissues , 2008, Histochemistry and Cell Biology.

[4]  J. Fridlyand,et al.  Chromosomal aberrations in angioimmunoblastic T‐cell lymphoma and peripheral T‐cell lymphoma unspecified: A matrix‐based CGH approach , 2007, Genes, chromosomes & cancer.

[5]  D. Ward,et al.  Karyotyping human chromosomes by combinatorial multi-fluor FISH , 1996, Nature Genetics.

[6]  R. Siebert,et al.  FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue. , 2006, The Journal of molecular diagnostics : JMD.

[7]  L. Kearney,et al.  Multiplex-FISH (M-FISH): technique, developments and applications , 2006, Cytogenetic and Genome Research.

[8]  A. Tchirkov,et al.  Gene dosage methods as diagnostic tools for the identification of chromosome abnormalities. , 2008, Pathologie-biologie.

[9]  N. Karandikar,et al.  Simple karyotype and bcl-6 expression predict a diagnosis of Burkitt lymphoma and better survival in IG-MYC rearranged high-grade B-cell lymphomas , 2010, Modern Pathology.

[10]  T. Molina,et al.  Improved reliability of lymphoma diagnostics via PCR-based clonality testing: — Report of the BIOMED-2 Concerted Action BHM4-CT98-3936 , 2007, Leukemia.

[11]  J. V. van Dongen,et al.  BIOMED-2 multiplex immunoglobulin/T-cell receptor polymerase chain reaction protocols can reliably replace Southern blot analysis in routine clonality diagnostics. , 2005, The Journal of molecular diagnostics : JMD.

[12]  Karin Jirström,et al.  From bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 28, 2013. For personal use only. , 2006 .

[13]  P. Gaulard,et al.  Detection by the fluorescence in situ hybridization technique of MYC translocations in paraffin‐embedded lymphoma biopsy samples , 2003, British journal of haematology.

[14]  E. Schuuring,et al.  Interphase FISH detection of BCL2 rearrangement in follicular lymphoma using breakpoint‐flanking probes , 2000, Genes, chromosomes & cancer.

[15]  R. Gascoyne,et al.  Genomic profiling reveals different genetic aberrations in systemic ALK‐positive and ALK‐negative anaplastic large cell lymphomas , 2008, British journal of haematology.

[16]  M. Møller,et al.  Validation of Putative Reference Genes for Normalization of Q-RT-PCR Data From Paraffin-embedded Lymphoid Tissue , 2009, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[17]  A. Rosenwald,et al.  Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma. , 2010, Cancer research.

[18]  D. de Jong,et al.  Commentary on the WHO classification of tumors of lymphoid tissues (2008): indolent B cell lymphomas , 2009, Journal of hematopathology.

[19]  D. G. Nord.  Refined characterisation of chromosome aberrations in tumours by multicolour banding and electronic mapping resources , 2001 .

[20]  A. Rosenwald,et al.  Diagnostic and prognostic significance of gene expression profiling in lymphomas , 2007, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[21]  L. Peterson,et al.  Nuclear expression of sox11 is highly associated with mantle cell lymphoma but is independent of t(11;14)(q13;q32) in non-mantle cell B-cell neoplasms , 2010, Modern Pathology.

[22]  S. Barrans,et al.  A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial). , 2008, Blood.

[23]  A. Mottok,et al.  Double-staining chromogenic in situ hybridization as a useful alternative to split-signal fluorescence in situ hybridization in lymphoma diagnostics , 2010, Haematologica.

[24]  R. Siebert.  Mature B‐ and T‐cell neoplasms and Hodgkin lymphoma , 2010 .

[25]  L. Staudt,et al.  SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype , 2009, Haematologica.

[26]  R. Gascoyne,et al.  Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival. , 2009, Blood.

[27]  L. Staudt,et al.  Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformation. , 2009, Blood.

[28]  R. Siebert,et al.  Chromosomal imbalances and partial uniparental disomies in primary central nervous system lymphoma , 2009, Leukemia.

[29]  E. Campo,et al.  Integrated genomic and expression profiling in mantle cell lymphoma: identification of gene‐dosage regulated candidate genes , 2008, British journal of haematology.

[30]  J W Gray,et al.  Cytogenetic profiling using fluorescence in situ hybridization (FISH) and comparative genomic hybridization (CGH) , 1993, Journal of cellular biochemistry. Supplement.

[31]  T. Molina,et al.  Polymerase chain reaction-based clonality testing in tissue samples with reactive lymphoproliferations: usefulness and pitfalls. A report of the BIOMED-2 Concerted Action BMH4-CT98-3936 , 2007, Leukemia.

[32]  Thomas Ried,et al.  Hidden chromosome abnormalities in haematological malignancies detected by multicolour spectral karyotyping , 1997, Nature Genetics.

[33]  E. Schuuring,et al.  Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma. , 1995, Blood.

[34]  R. Siebert,et al.  Interphase cytogenetics of hematological neoplasms under the perspective of the novel WHO classification. , 2003, Anticancer research.

[35]  L. Rimsza,et al.  Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphoma , 2010, Haematologica.

[36]  S. Armstrong,et al.  Genome-wide SNP analysis in cancer: leukemia shows the way. , 2007, Cancer cell.

[37]  A. Carbone,et al.  B-cell lymphomas with features intermediate between distinct pathologic entities. From pathogenesis to pathology. , 2010, Human pathology.

[38]  P. Moreau,et al.  The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement , 2007, Haematologica.

[39]  H. Tagawa,et al.  The potential of copy number gains and losses, detected by array-based comparative genomic hybridization, for computational differential diagnosis of B-cell lymphomas and genetic regions involved in lymphomagenesis , 2009, Haematologica.

[40]  Xavier Estivill,et al.  Uniparental disomies, homozygous deletions, amplifications, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profiling. , 2009, Blood.

[41]  E. Jordanova,et al.  Hemizygous deletions in the HLA region account for loss of heterozygosity in the majority of diffuse large B‐cell lymphomas of the testis and the central nervous system , 2002, Genes, chromosomes & cancer.

[42]  L. Staudt,et al.  Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways , 2008, Proceedings of the National Academy of Sciences.

[43]  S. Barrans,et al.  Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  D. de Jong,et al.  Commentary on the WHO classification of tumors of lymphoid tissues (2008): “Gray zone” lymphomas overlapping with Burkitt lymphoma or classical Hodgkin lymphoma , 2009, Journal of hematopathology.

[45]  L. Staudt,et al.  Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma , 2009, Proceedings of the National Academy of Sciences.

[46]  S. Barrans,et al.  The detection of t(14;18) in archival lymph nodes: development of a fluorescence in situ hybridization (FISH)-based method and evaluation by comparison with polymerase chain reaction. , 2003, The Journal of molecular diagnostics : JMD.

[47]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[48]  J. Chan,et al.  Consistent Immunostaining for Cyclin D1 Can Be Achieved on a Routine Basis Using a Newly Available Rabbit Monoclonal Antibody , 2004, The American journal of surgical pathology.

[49]  Brian D. Kelly,et al.  Automated brightfield break-apart in situ hybridization (ba-ISH) application: ALK and MALT1 genes as models. , 2010, Methods.

[50]  H. Kohlhammer,et al.  Further delineation of chromosomal consensus regions in primary mediastinal B-cell lymphomas: an analysis of 37 tumor samples using high-resolution genomic profiling (array-CGH) , 2007, Leukemia.

[51]  H. Döhner,et al.  Identification of genetic imbalances in malignant lymphoma using comparative genomic hybridization , 1995, Stem cells.

[52]  P. Jacobs,et al.  CYTOGENETIC STUDIES IN BURKITT'S LYMPHOMA. , 1963, Lancet.

[53]  D. Gisselsson.  Refined characterisation of chromosome aberrations in tumours by multicolour banding and electronic mapping resources. , 2001, Methods in cell science : an official journal of the Society for In Vitro Biology.

[54]  R. Spang,et al.  A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. , 2006, The New England journal of medicine.

[55]  D. Bostwick,et al.  Comparison of fluorescence in situ hybridization analysis of isolated nuclei and routine histological sections from paraffin-embedded prostatic adenocarcinoma specimens. , 1996, The American journal of pathology.

[56]  T. Molina,et al.  T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. , 2001, Gastroenterology.

[57]  P. N. Rao,et al.  Guidance for fluorescence in situ hybridization testing in hematologic disorders. , 2007, The Journal of molecular diagnostics : JMD.

[58]  B. Falini,et al.  Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry. , 2002, Blood.

[59]  M Hummel,et al.  Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936 , 2003, Leukemia.

[60]  P. Nowell,et al.  Chromosome studies on normal and leukemic human leukocytes. , 1960, Journal of the National Cancer Institute.

[61]  B. Sander,et al.  The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival , 2008, British journal of haematology.

[62]  A. Iafrate,et al.  A Novel, Highly Sensitive Antibody Allows for the Routine Detection of ALK-Rearranged Lung Adenocarcinomas by Standard Immunohistochemistry , 2010, Clinical Cancer Research.

[63]  P. Dessen,et al.  High Resolution Genome-Wide Analysis of Chromosomal Alterations in Burkitt's Lymphoma , 2009, PloS one.

[64]  R. Siebert,et al.  Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge , 2008, Leukemia.

[65]  D. Gerhard,et al.  Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines. , 1996, Blood.

[66]  S. Pileri,et al.  CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. , 2000, Blood.

[67]  R. Siebert,et al.  Partial uniparental disomy: a recurrent genetic mechanism alternative to chromosomal deletion in malignant lymphoma , 2006, Leukemia.

[68]  E. Jordanova,et al.  Flow cytometric sorting of paraffin-embedded tumor tissues considerably improves molecular genetic analysis. , 2003, American journal of clinical pathology.

[69]  J Vrolijk,et al.  New strategy for multi-colour fluorescence in situ hybridisation: COBRA: COmbined Binary RAtio labelling , 1999, European Journal of Human Genetics.

[70]  E. Haralambieva,et al.  Interphase fluorescence in situ hybridization for detection of 8q24/MYC breakpoints on routine histologic sections: Validation in Burkitt lymphomas from three geographic regions , 2004, Genes, chromosomes & cancer.

[71]  T. Lister,et al.  Genome-wide detection of recurring sites of uniparental disomy in follicular and transformed follicular lymphoma , 2007, Leukemia.

[72]  M. Seto,et al.  Diversity of genome profiles in malignant lymphoma , 2010, Cancer science.

[73]  Stefan Heinrichs,et al.  SNP array analysis in hematologic malignancies: avoiding false discoveries. , 2010, Blood.

[74]  E. Haralambieva,et al.  Detection of three common translocation breakpoints in non‐Hodgkin's lymphomas by fluorescence in situ hybridization on routine paraffin‐embedded tissue sections , 2002, The Journal of pathology.

[75]  M. Eriksson,et al.  Pre-emptive treatment with rituximab of molecular relapse after autologous stem cell transplantation in mantle cell lymphoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[76]  N. Nakamura,et al.  Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations , 2009, Haematologica.

[77]  E. Schuuring,et al.  Direct visualization of dispersed 11q13 chromosomal translocations in mantle cell lymphoma by multicolor DNA fiber fluorescence in situ hybridization. , 1996, Blood.

[78]  A. Weeks,et al.  Letter: Ectopic pregnancy and the I.U.D. , 1975, Lancet.

[79]  C. V. van Noesel,et al.  Effects of Processing Delay, Formalin Fixation, and Immunohistochemistry on RNA Recovery From Formalin-fixed Paraffin-embedded Tissue Sections , 2008, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[80]  P. Lichter,et al.  Comparative genomic hybridization: uses and limitations. , 2000, Seminars in hematology.

[81]  A. Rosenwald,et al.  Genomic alterations and gene expression in primary diffuse large B‐cell lymphomas of immune‐privileged sites: the importance of apoptosis and immunomodulatory pathways , 2008, The Journal of pathology.

[82]  C. J. Boer,et al.  Bcl-1/cyclin D1 in malignant lymphoma. , 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

[83]  L. Staudt,et al.  Chromosomal alterations detected by comparative genomic hybridization in subgroups of gene expression-defined Burkitt’s lymphoma , 2008, Haematologica.

[84]  Randy D Gascoyne,et al.  Comprehensive whole genome array CGH profiling of mantle cell lymphoma model genomes. , 2004, Human molecular genetics.

[85]  A. Jauch,et al.  Concurrent activation of a novel putative transforming gene, myeov, and cyclin D1 in a subset of multiple myeloma cell lines with t(11;14)(q13;q32). , 2000, Blood.